ITIF Logo
ITIF Search

Adams Nager

Adams

Former Economic Policy Analyst

Information Technology and Innovation Foundation

Twitter: @Adams_Nager

Adams Nager was formerly an economic policy analyst at the Information Technology and Innovation Foundation. He researches and writes on innovation economics, manufacturing policy, and the importance of STEM education and high-skilled immigration. Nager holds an M.A. in political economy and public policy and a B.A. in economics, both from Washington University in St. Louis.

Recent Publications

April 19, 2017

Trump’s Review of H-1B Visas Should Make a Good Program Better

As long as the administration recognizes the need to continue attracting the world’s best and brightest—and takes a careful, “mend it, don’t end it” approach to carrying out the president’s order—the result can be beneficial for the U.S. economy, writes Adams Nager on MarketWatch.

March 17, 2017

Trump’s Cuts to Federal Science Funding Will Mean Less Industry R&D, Not More

President Trump assumes crowded out private investment will restore R&D expenditures after deep budget cuts, but evidence disagrees, writes Adams Nager in Innovation Files.

March 17, 2017

Architecting an Innovation-Maximizing Global Economic and Trade System

The international community needs to work assiduously to architect a global innovation system supported by innovation-empowering trade rules and well-constructed domestic policies to spur innovation.

February 22, 2017

Can U.S. Manufacturing Be Made Great Again?

It’s time to change the narrative that U.S. manufacturing jobs are being lost to robots in a rapid shift to high-tech “factories of the future” that pushes U.S. manufacturing output to an all-time high, write Adams Nager and Rob Atkinson in IndustryWeek.

February 13, 2017

Trade vs. Productivity: What Caused U.S. Manufacturing's Decline and How to Revive It

Automation was not the primary culprit behind manufacturing job losses, and now too little automation is depressing U.S. output and leading to stagnation in U.S. manufacturing.

February 6, 2017

A Tale of Two Trading Partners: Why U.S. Trade With Mexico and China Could Not Be More Different

The differences in the United States’ relationship with these two nations shows the need for a more nuanced discussion on trade, writes Adams Nager in Innovation Files.

January 17, 2017

Is the United States Immune to Dutch Disease?

Adams Nager writes in Innovation Files that as the United States celebrates an oil boom, the question must be asked: Is the United States immune to Dutch Disease?

January 3, 2017

End the Conspiracy of Silence

Adams Nager writes in International Economy that the election of Donald Trump was a body blow to the so-called “Washington trade consensus,” a coherent, if intellectually flawed, set of beliefs which holds that trade always benefits the U.S. economy and that any efforts to restrict it, even in the service of ensuring that our trading partners play by the rules, by definition is detrimental to economic growth.

November 28, 2016

High-Tech Nation: How Technological Innovation Shapes America’s 435 Congressional Districts

America’s innovation-driven, high-tech economy isn’t concentrated around a few hubs like Silicon Valley; it is widely diffused—and every state and congressional district has a stake in its success.

October 17, 2016

Does Inequality Hinge on Too Much Automation or Not Enough?

Too little, not too much, technology may be responsible for slow median wage growth that frustrates voters this election, writes Adams Nager in Innovation Files.

October 11, 2016

Comments to the U.S. Department of Homeland Security on International Entrepreneurs

ITIF applauds the intention of the U.S. Department of Homeland Security’s proposed rule on international entrepreneurs, but as currently written, the rule could be applied to individuals and companies that would have negligible impact on U.S. job growth, innovation, and productivity.

July 11, 2016

A Trillion-Dollar Opportunity: How Brain Research Can Drive Health and Prosperity

Spurring biopharmaceutical innovation to understand and cure brain diseases and disorders could improve health outcomes for more than 50 million Americans while increasing GDP by up to $1.5 trillion or more.

More publications by Adams Nager

Recent Events and Presentations

July 11, 2016

A Trillion-Dollar Opportunity: How Brain Research Can Drive Health and Prosperity

Join ITIF for the release of a new report examining the potential economic gains the United States could reap from biopharma innovation that enables improved diagnosis, treatment, cures, and even prevention of mental and neurological health conditions.

Back to Top